M.D., Ph.D., Co-founder and SVP, Immunology, Walking Fish Tx
Biography
Mark has been dedicated to advancing immune-modulatory therapeutic options for patients. Currently, he is developing in vivo B cell protein factories providing durable expression of proteins of therapeutic value, exploiting the ability of B cells to produce immunoglobulin proteins at high levels and to persist for decades.
Mark started his industry career at Chiron Vaccines, working with Michael Houghton on exploring the HCV polyprotein for vaccines and subsequently on in vivo DNA delivery platforms to induce cellular immune responses. Thereafter, Mark worked with Dr. Alan Korman at Medarex, advancing fully human immune-modulatory antibodies derived from immunized transgenic mice. Mark is a co-inventor of the anti-PD-1 antibody Nivolumab (Opdivo), the first anti-PD-1 antibody to enter the clinic. Mark is co-inventor of the Nivolumab/Ipilumumab combination as well as the recently approved anti-LAG-3 antibody.
Session Abstract – PMWC 2023 Silicon Valley
Track 1 - January 26 9.00 A.M.-4.30 P.M.
Track Chair: Sharon Benzeno, Adaptive Biotechnologies
- PMWC 2023 Luminary Award Ceremony
Honoree: Bruce Levine, University of Pennsylvania
- Advance and Optimize Cell Therapies in Oncology (PANEL)
Chair: Sharon Benzeno, Adaptive Biotechnologies
- Ira Mellman, Genenetch
- Mark Selby, Walking Fish Therapeutics
- Sneha Ramakrishna, Stanford
- Loïc VINCENT, Affini-T Therapeutics
- Nick Haining, Arsenal
- Warner Biddle, Kite - Pioneering Cell Therapies in the Treatment of Autoimmune Disorders (PANEL)
Chair: Carl June, UPenn
- Lenny Dragone, Sonoma
- James Chung, Kyverna
- David Chang, Cabaletta
- Cristina Musselli, Abata Therapeutics - Innovations in Cell Therapy Manufacturing (PANEL)
Chair: Bruce Levine, University of Pennsylvania
- Chris Holt, BMS
- Heidi Hagen, Sonoma Bio
- Rahul Singhvi, Resilience
- Snehal Patel, Sana Biotechnology - Patentability of Immunotherapies - Latest Developments
- Janet Xiao, Morrison & Foerster LLP
- Investing in Gene-Modified Cell Therapies
Chair: Karen Tkach Tuzman, BioCentury Inc.
- Robert Lin, UPMC
- Yvonne Yamanaka, venBio
- Abraham Bassan, Samsara Capital
- Brian Daniels, 5am Ventures
- Leveraging Data Sets to Inform Future Drug Discovery and Development (PANEL)
Chair: Jason Coloma, Maze Therapeutics
- Peter DiLaura, Sonoma Bio
- Nick Haining, Arsenal
- Kwame Okrah, Parker Institute
- Dan Kirouac, Notch Therapeutics
